Markets

Mangoceuticals Closes Registered Direct Offering Following $2.5M Strategic Investment Commitment In MangoRx IP Holdings To Support Intellectual Property Commercialization

Oct 9, 2026 · 04:03 PM ET· updated 46m ago

Transaction follows a $2.5 million strategic investment commitment at MangoRx IP Holdings to support intellectual property commercializationDALLAS, TX, Oct. 09, 2026 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc.

Why It Matters

Mangoceuticals raised $2.5 million to help develop and sell new inventions. When a company gets money for new ideas, watch if those ideas actually become real products.

This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.

Tickers in Play

MGRX0.40

-0.03 (-7.49%)

Last session drawn · prints held ~15 minutes · licensed exchange data

Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.

Disclosure: Educational and informational purposes only. Not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.